Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study

Background and Aim: To evaluate the clinical effect of ultrasound (US)-guided percutaneous thermal ablation of hepatic focal nodular hyperplasia (FNH).Methods: A retrospective analysis of the clinical data of patients undergoing US-guided percutaneous thermal ablation of FNH from November 2008 to Au...

Full description

Bibliographic Details
Main Authors: Xuan Yu, Jiandong Chang, Dezhi Zhang, Qiang Lu, Songsong Wu, Kai Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2021.826926/full
_version_ 1818965741547814912
author Xuan Yu
Jiandong Chang
Dezhi Zhang
Qiang Lu
Songsong Wu
Kai Li
author_facet Xuan Yu
Jiandong Chang
Dezhi Zhang
Qiang Lu
Songsong Wu
Kai Li
author_sort Xuan Yu
collection DOAJ
description Background and Aim: To evaluate the clinical effect of ultrasound (US)-guided percutaneous thermal ablation of hepatic focal nodular hyperplasia (FNH).Methods: A retrospective analysis of the clinical data of patients undergoing US-guided percutaneous thermal ablation of FNH from November 2008 to August 2021 at five medical centers in China was conducted.Results: A total of 53 patients were included (26 males and 27 females). The mean age was 35.1 ± 10.8 years. Sixty-five lesions (46 solitary cases and 7 cases with multiple lesions) were included, 70.8% (46/65) of which were located in the right liver lobe. The mean tumor length was 2.9 ± 1.5 cm. All patients successfully completed the ablation treatment. Immediate postoperative imaging showed that the primary technical success rate was 94.3% (50/53). Two patients underwent ablation 3 and 6 months after the primary ablation, and the secondary technical success rate was 100% (2/2). The incidence of complications was 3.8% (2/53). Imaging follow-up was conducted regularly after ablation, and no residual lesion enlargement or tumor recurrence was observed during the follow-up period. The technique efficacy rate was 98.1% (52/53).Conclusion: US-guided percutaneous thermal ablation is a safe and effective treatment for FNH of the liver.
first_indexed 2024-12-20T13:21:50Z
format Article
id doaj.art-d7d1b58441c14597a84ec8636f5d09a7
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-12-20T13:21:50Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-d7d1b58441c14597a84ec8636f5d09a72022-12-21T19:39:24ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852022-01-01910.3389/fbioe.2021.826926826926Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective StudyXuan Yu0Jiandong Chang1Dezhi Zhang2Qiang Lu3Songsong Wu4Kai Li5Department of Medical Ultrasonics, The Third Affiliated Hospital of Sun Yat-sen University, Guangdong, ChinaDepartment of Ultrasound, Xiamen Chinese Medical Hospital, Fujian, ChinaDepartment of Ultrasound, The First Hospital of Jilin University, Jilin, ChinaDepartment of Ultrasound, West China Hospital, Sichuan, ChinaDepartment of Ultrasonography, Shengli Clinical Medical College of Fujian Medical University, Fujian, ChinaDepartment of Medical Ultrasonics, The Third Affiliated Hospital of Sun Yat-sen University, Guangdong, ChinaBackground and Aim: To evaluate the clinical effect of ultrasound (US)-guided percutaneous thermal ablation of hepatic focal nodular hyperplasia (FNH).Methods: A retrospective analysis of the clinical data of patients undergoing US-guided percutaneous thermal ablation of FNH from November 2008 to August 2021 at five medical centers in China was conducted.Results: A total of 53 patients were included (26 males and 27 females). The mean age was 35.1 ± 10.8 years. Sixty-five lesions (46 solitary cases and 7 cases with multiple lesions) were included, 70.8% (46/65) of which were located in the right liver lobe. The mean tumor length was 2.9 ± 1.5 cm. All patients successfully completed the ablation treatment. Immediate postoperative imaging showed that the primary technical success rate was 94.3% (50/53). Two patients underwent ablation 3 and 6 months after the primary ablation, and the secondary technical success rate was 100% (2/2). The incidence of complications was 3.8% (2/53). Imaging follow-up was conducted regularly after ablation, and no residual lesion enlargement or tumor recurrence was observed during the follow-up period. The technique efficacy rate was 98.1% (52/53).Conclusion: US-guided percutaneous thermal ablation is a safe and effective treatment for FNH of the liver.https://www.frontiersin.org/articles/10.3389/fbioe.2021.826926/fullfocal nodular hyperplasiaultrasonographyradiofrequency ablationmicrowave ablationthermal ablation
spellingShingle Xuan Yu
Jiandong Chang
Dezhi Zhang
Qiang Lu
Songsong Wu
Kai Li
Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study
Frontiers in Bioengineering and Biotechnology
focal nodular hyperplasia
ultrasonography
radiofrequency ablation
microwave ablation
thermal ablation
title Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study
title_full Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study
title_fullStr Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study
title_full_unstemmed Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study
title_short Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study
title_sort ultrasound guided percutaneous thermal ablation of hepatic focal nodular hyperplasia a multicenter retrospective study
topic focal nodular hyperplasia
ultrasonography
radiofrequency ablation
microwave ablation
thermal ablation
url https://www.frontiersin.org/articles/10.3389/fbioe.2021.826926/full
work_keys_str_mv AT xuanyu ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy
AT jiandongchang ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy
AT dezhizhang ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy
AT qianglu ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy
AT songsongwu ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy
AT kaili ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy